Novartis was aware of manipulation of data supporting gene therapy approval, FDA says
RUBY WALLAU FOR STAT
In a statement, the agency said it will "use its full authorities to take action, if appropriate, which may include civil or criminal penalties."
No hay comentarios:
Publicar un comentario